SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

11 Feb 2025 Evaluate
Net sales declined -14.07%  to  Rs. 362.70 million from Rs. 422.10 millions.A big decline of -38.65% was reported for the quarter ended December 2024 to Rs. 28.10  millions from Rs. 45.80 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 74.00 millions from 92.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 362.70 422.10 -14.07 1359.30 1317.50 3.17 1685.18 2226.85 -24.32
Other Income 118.80 134.40 -11.61 386.70 330.10 17.15 459.80 282.42 62.81
PBIDT 74.00 92.90 -20.34 301.10 120.80 149.25 193.16 18.82 926.35
Interest 11.70 11.50 1.74 29.80 33.40 -10.78 43.61 25.13 73.54
PBDT 59.20 81.40 -27.27 225.00 24.90 803.61 87.01 -6.31 -1478.92
Depreciation 22.40 20.50 9.27 63.60 68.30 -6.88 89.40 91.15 -1.92
PBT 36.80 60.90 -39.57 161.40 -43.40 -471.89 -2.39 -97.46 -97.55
TAX 8.70 15.10 -42.38 45.70 -12.00 -480.83 -8.61 -36.66 -76.51
Deferred Tax 1.40 10.50 -86.67 18.00 -16.60 -208.43 -13.20 -30.94 -57.34
PAT 28.10 45.80 -38.65 115.70 -31.40 -468.47 6.22 -60.80 -110.23
Equity 500.60 498.90 0.34 500.60 498.90 0.34 498.86 498.86 0.00
PBIDTM(%) 20.40 22.01 -7.30 22.15 9.17 141.59 11.46 0.85 1256.32

Viyash Scientific Share Price

209.00 0.65 (0.31%)
22-Apr-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.20
Dr. Reddys Lab 1220.70
Cipla 1233.85
Zydus Lifesciences 931.20
Lupin 2307.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×